Related Experiment Video
Updated: Mar 28, 2026

Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
Published on: February 4, 2021
Increased Aortic Valve Calcification in Familial Hypercholesterolemia: Prevalence, Extent, and Associated Risk
Gert-Jan R Ten Kate1, Sven Bos2, Admir Dedic1
1Department of Radiology, Erasmus Medical Centre, Rotterdam, the Netherlands; Interuniversitair Cardiologisch Instituut Nederland, Utrecht, the Netherlands; Department of Cardiology, Thorax Centre Rotterdam, Rotterdam, the Netherlands.
Insights
Heterozygous familial hypercholesterolemia (he-FH) is linked to increased aortic valve calcification (AoVC). LDLR-negative mutations are the strongest predictor of AoVC extent, emphasizing LDL-C metabolism
Area of Science:
- Cardiovascular Medicine
- Genetics
- Radiology
Background:
- Familial hypercholesterolemia (FH) is characterized by elevated LDL cholesterol (LDL-C) due to LDL receptor (LDLR) mutations.
- Homozygous FH exhibits 100% prevalence of symptomatic aortic valve calcification (AoVC).
- The prevalence and risk factors for AoVC in heterozygous FH (he-FH) are not well understood.
Purpose of the Study:
- To determine the prevalence and extent of subclinical AoVC in asymptomatic he-FH patients.
- To identify risk modifiers associated with AoVC in he-FH.
- To compare AoVC in he-FH patients versus non-FH controls.
Main Methods:
- 145 asymptomatic he-FH patients and 131 controls underwent CT calcium scoring.
- AoVC was defined by calcium in aortic valve leaflets; extent was measured by AoVC-score (Agatston units).
- Risk modifiers investigated included LDLR mutation status (LDLR-negative), maximum untreated LDL-C (maxLDL), LDL-C, blood pressure, and coronary artery calcification (CAC).
Main Results:
- AoVC prevalence (41% vs 21%) and AoVC-score (51 vs 21) were significantly higher in he-FH patients compared to controls (p < 0.001 and p = 0.007, respectively).
- Independent predictors of AoVC included age, untreated maxLDL, CAC, and diastolic blood pressure.
- LDLR-negative mutations were the strongest predictor of AoVC-score (OR: 4.81; p < 0.001).
Conclusions:
- Asymptomatic he-FH is associated with a high prevalence and significant extent of subclinical AoVC.
- LDLR-negative mutations represent a critical risk factor for AoVC in he-FH.
- These findings underscore the crucial role of LDL-C metabolism in the etiology of AoVC.
Background:
Familial hypercholesterolemia is typically caused by LDL receptor (LDLR) mutations that result in elevated levels of LDL cholesterol (LDL-C). In homozygous FH, the prevalence of aortic valve calcification (AoVC) reaches 100% and is often symptomatic.
Objectives:
The objective of this study was to investigate the prevalence, extent, and risk-modifiers of AoVC in heterozygous FH (he-FH) that are presently unknown.
Methods:
Asymptomatic patients with he-FH and 131 non-familial hypercholesterolemia controls underwent CT computed tomography calcium scoring. AoVC was defined as the presence of calcium at the aortic valve leaflets. The extent of AoVC was expressed in Agatston units, as the AoVC-score. We compared the prevalence and extent of AoVC between cases and controls. In addition, we investigated risk modifiers of AoVC, including the presence of LDLR mutations without residual function (LDLR-negative mutations), maximum untreated LDL-cholesterol (maxLDL), LDL-C, blood pressure, and coronary artery calcification (CAC).
Results:
We included 145 asymptomatic patients with he-FH (93 men; mean age 52 ± 8 years) and 131 non-familial hypercholesterolemia controls. The prevalence (%) and AoVC-score (median, IQR) were higher in he-FH patients than in controls: 41%, 51 (9-117); and 21%, 21 (3-49) (p < 0.001 and p = 0.007). Age, untreated maxLDL, CAC, and diastolic blood pressure were independently associated with AoVC. LDLR-negative mutational he-FH was the strongest predictor of the AoVC-score (OR: 4.81; 95% CI: 2.22 to 10.40; p = <0.001).
Conclusions:
Compared to controls, he-FH is associated with a high prevalence and a large extent of subclinical AoVC, especially in patients with LDLR-negative mutations, highlighting the critical role of LDL-C metabolism in AoVC etiology.
Related Concept Videos
Coronary Artery Disease I: Introduction
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Atherosclerosis I: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Coronary Artery Disease II: Pathophysiology
Aortic Regurgitation II: Clinical Features and Diagnostic Tests

